Drug Benefit Lists Table of Contents

Welcome to the iDBL

Section 1-Policies and Guidelines (PDF)

Introduction (PDF)

  • Eligibility
  • Additional Notes Regarding Application of the List
  • Legend
  • Example of Drug Product Listings
  • Acknowledgements
  • Drug Review Procedure

Alberta Health Expert Committee on Drug Evaluation and Therapeutics (PDF)

Submission and Drug Review Process (PDF)

  • Submission Requirements and Criteria
  • Interpretation Notices
  • Submission Requirements
  • Criteria for Listing Drug Products
  • Interchangeable Drug Products
  • Review of Benefit Status (ROBS) Criteria
  • Supply Shortage Policy for Drug Products
  • Policy for Administering Interchangeability Challenges
  • Your Comments are Important to Us

Units of Issue for Pricing (PDF)

Price Policy-Amended February 16, 2024 (PDF)

Restricted Benefits (PDF)

  • Restricted Benefits
  • Products Designated as Restricted Benefits
  • Limited Restricted Benefits
  • Products Designated as Limited Restricted Benefits

Special Authorization Guidelines (PDF)

  • Special Authorization Policy
  • Special Authorization Procedures
  • Special Authorization Forms
  • Prescriber Registration Forms

Special Authorization Forms

Notice:

The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.

Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross® who publishes them on behalf of Alberta Health and Alberta Human Services.

Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL (iDBL), and any such changes to the Interactive DBL (iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.